Pinus sp. leaf extracts exert antileishmanial effects against Leishmania donovani by targeting trypanothione reductase

This study demonstrates that Pinus sp. leaf extracts exhibit potent, non-toxic antileishmanial activity against Leishmania donovani through antioxidant and immunomodulatory effects, with metabolomic and in silico analyses suggesting that flavanone O-glycosides, alkaloids, and diterpenes within the extracts inhibit the parasite via trypanothione reductase.

The Gist

🌲 The Pine Tree's Secret Weapon Against a Sneaky Invader

Imagine a microscopic invader called Leishmania. It's a tiny parasite that hides inside your body's security guards (immune cells) and causes a serious disease called Leishmaniasis. Currently, the weapons we use to fight it (modern medicines) are like blunt hammers: they are expensive, can hurt the patient (toxicity), and the parasite is starting to learn how to dodge them (resistance).

Scientists in Cameroon decided to look for a new weapon in an old place: the Pine tree (Pinus species). In local traditions, pine leaves are used to treat fevers and coughs. The researchers asked: Could these pine leaves also kill this sneaky parasite?

🔬 The Experiment: Testing the Pine "Tea"

The team took pine leaves and made four different "teas" (extracts) using different liquids: pure ethanol, pure methanol, and mixtures of water with those liquids. They then tested these teas against the parasite in two different forms:

1. The Swimmer (Promastigote): The form the parasite takes when it's outside the body in the sandfly.
2. The Hider (Amastigote): The form it takes when it's hiding inside human cells.

The Result: The pine teas worked! They stopped the parasites from growing. The most effective tea was the ethanol extract. It was like a sniper shot, killing the parasite at very low doses while leaving human cells completely unharmed.

🛡️ How Does It Work? (The Triple Threat)

The paper suggests the pine extract doesn't just attack the parasite directly; it fights on three fronts:

1. The Shield Breaker (Antioxidant): Parasites love to create chaos (oxidative stress) to survive. The pine extract acts like a super-shield, neutralizing that chaos.
2. The Alarm System (Immunomodulatory): The extract wakes up the body's security guards (macrophages) and tells them to release "nitric oxide," a toxic gas that kills the parasite. It's like ringing the fire alarm and spraying the intruder with a fire hose.
3. The Calm Down (Anti-inflammatory): It stops the body from overreacting and hurting itself, acting like a soothing balm for the inflammation caused by the infection.

🔍 The "Black Box" Investigation: What's Inside?

To find out which specific chemicals in the pine leaves were doing the work, the scientists used a high-tech machine (UHPLC-MS) to look inside the extract. It's like using an X-ray to see the ingredients in a mystery soup.

They found three main "heroes":

• Harmane: A chemical that acts like a master key.
• Abietic Acid: A compound that acts like a heavy hammer.
• Epiafzelechin Trimethyl Ether: A chemical that acts like a precise lockpick.

🎮 The Virtual Video Game: Molecular Docking

Before testing these chemicals in real life, the scientists played a "video game" (computer simulation) called Molecular Docking.

• The Target: They focused on a specific machine inside the parasite called Trypanothione Reductase. Think of this machine as the parasite's life-support system. It's the engine that keeps the parasite alive and protects it from oxygen attacks. Humans don't have this engine; we use a different one. This makes it a perfect target!
• The Simulation: They dropped the pine chemicals into the virtual engine room.
• The Winner: Harmane was the star player. It fit into the engine's lock perfectly and jammed it shut with a binding energy of -8.2 kcal/mol. It was a tighter fit than the current expensive drugs (Amphotericin B and Miltefosine).

🐭 The Safety Check: Is It Poisonous?

Before we can use a new medicine, we must make sure it doesn't kill the patient. The researchers fed a massive dose of the pine extract (5,000 mg/kg) to rats.

• The Outcome: The rats were fine. They didn't get sick, they didn't lose weight, and their organs (liver and kidneys) looked healthy under a microscope.
• The Verdict: The extract is non-toxic. It's safe enough to be considered a potential medicine.

⚠️ The Catch (Limitations)

While this is exciting news, the story isn't finished yet.

• The "Soup" Problem: Right now, we have the whole "soup" (the extract) that works. But to make a real pill, we need to isolate the exact ingredient (the "spice") that does the work.
• The "Harmane" Warning: While the pine extract is safe, one of the isolated chemicals (Harmane) showed a small risk of toxicity in the computer models. Scientists need to figure out if this is a real risk or just a glitch in the simulation.
• Next Steps: We need to test this in real animals with the disease and figure out exactly how it kills the parasite step-by-step.

🏁 The Bottom Line

This study is like finding a treasure map. It shows that Pine leaves contain a powerful, safe, and effective natural weapon against a deadly parasite. The "engine" of the parasite (Trypanothione Reductase) has been jammed by chemicals found in the pine.

While we aren't ready to go to the pharmacy and buy "Pine Cure" pills yet, this research proves that nature might hold the key to a new, cheaper, and safer way to fight Leishmaniasis. The next step is to refine the recipe and turn this natural discovery into a real medicine.

Technical Summary

1. Problem Statement

Leishmaniasis is a neglected tropical disease caused by Leishmania parasites, with visceral leishmaniasis being the most fatal form. Current treatments (e.g., pentavalent antimonials, amphotericin B, miltefosine) face significant challenges, including high toxicity, emerging drug resistance, complex administration requirements, and high costs. There is an urgent need for novel antileishmanial agents with new mechanisms of action. The study focuses on Pinus species, widely used in the Cameroonian pharmacopoeia for treating fevers and infections, to scientifically validate their potential as a source of new antileishmanial drugs.

2. Methodology

The study employed a multi-disciplinary approach combining in vitro biological assays, in vivo toxicity studies, metabolomics, and in silico modeling.

• Plant Material & Extraction: Pinus sp. leaves were collected, dried, and ground. Four extracts were prepared using different solvents: Ethanol (Ps.FEtOH), Methanol (Ps.FMeOH), Hydro-ethanol (30:70 v/v), and Hydro-methanol (30:70 v/v).
• Biological Assays (In Vitro):
  • Antileishmanial Activity: Evaluated against L. donovani promastigotes and intracellular amastigotes using a resazurin-based colorimetric assay.
  • Cytotoxicity: Assessed on RAW 264.7 (macrophages) and Vero CRL1586 (kidney) cell lines using the Alamar Blue assay to determine Selectivity Indices (SI).
  • Immunomodulation: Measured Nitric Oxide (NO) production in infected macrophages via the Griess reaction.
  • Anti-inflammatory: Evaluated via Bovine Serum Albumin (BSA) protein denaturation assay.
  • Antioxidant: Assessed using DPPH, ABTS, and Ferric Reducing Antioxidant Power (FRAP) tests.
• Acute Toxicity (In Vivo): The most promising extract was tested in female Wistar rats at doses of 2000 and 5000 mg/kg following OECD Guideline 423. Parameters included mortality, behavioral changes, body weight, organ weights, hematology, and biochemical markers (liver/kidney function), followed by histological analysis.
• Phytochemical Analysis: The active extract underwent UHPLC-LC-MS/MS metabolomic profiling to identify bioactive compounds.
• In Silico Studies:
  • ADMET Prediction: Used the ADMET-AI platform to predict absorption, distribution, metabolism, excretion, and toxicity of identified compounds.
  • Molecular Docking: Simulated interactions between identified compounds and Leishmania infantum Trypanothione Reductase (TR) (PDB ID: 6ER5), the target enzyme essential for parasite redox balance.

3. Key Contributions

• Validation of Ethnomedicine: Scientifically validates the traditional use of Pinus sp. for treating fever-related conditions by demonstrating potent antileishmanial activity.
• Multi-Target Mechanism: Proposes a polypharmacological approach where the extracts act not only by directly inhibiting the parasite but also by modulating the host immune system (increasing NO) and reducing oxidative stress/inflammation.
• Identification of Lead Compounds: Successfully identified specific secondary metabolites (Harmane, Abietic acid, Epiafzelechin trimethyl ether) responsible for the activity.
• Target Validation: Provides computational evidence that these compounds bind strongly to Trypanothione Reductase, a target unique to kinetoplastid parasites, suggesting high selectivity over human enzymes.

4. Key Results

A. Antileishmanial and Cytotoxicity Activity

• All extracts showed dose-dependent inhibition of L. donovani.
• IC50 Values:
  • Promastigotes: Ranged from 6.45 µg/mL (Methanol extract) to 15.78 µg/mL.
  • Amastigotes: Ranged from 16.11 µg/mL (Ethanol extract) to 24.44 µg/mL.
• Selectivity: All extracts demonstrated high selectivity (SI > 10, often >50) against mammalian cells (RAW and Vero), indicating low toxicity to host cells.
• The Ethanol extract (Ps.FEtOH) was selected for further study due to its balanced efficacy and safety profile.

B. Immunomodulatory and Anti-inflammatory Effects

• NO Production: Methanol, hydro-ethanolic, and hydro-methanolic extracts significantly increased NO production in infected macrophages at high concentrations (100 µg/mL), suggesting an immunomodulatory mechanism that aids parasite clearance.
• Anti-inflammatory: The hydro-methanolic extract showed the strongest anti-inflammatory activity (IC50 = 4.11 µg/mL) in the BSA denaturation assay, comparable to the reference drug Diclofenac (IC50 = 2.91 µg/mL).

C. Antioxidant Activity

• Extracts exhibited significant radical scavenging activity in DPPH, ABTS, and FRAP assays. The Methanol extract showed the highest DPPH scavenging activity (SC50 = 8.98 µg/mL), comparable to Ascorbic Acid.

D. Acute Toxicity (In Vivo)

• LD50: The Ethanol extract showed no mortality or toxicity signs up to 5000 mg/kg in rats.
• Physiological Impact: No significant changes were observed in body weight, organ weights, hematology, or liver/kidney biochemical markers (ALT, AST, Creatinine, Uric Acid) compared to controls.
• Histology: Liver and kidney tissues remained normal with no signs of necrosis or inflammation.

E. Phytochemical Profiling & Molecular Docking

• Identified Compounds: UHPLC-MS/MS identified 9 major compounds, including Harmane (alkaloid), Abietic acid (diterpene), and Epiafzelechin trimethyl ether (flavanone O-glycoside).
• ADMET Prediction:
  • Harmane, Abietic acid, and Epiafzelechin trimethyl ether complied with Lipinski's Rule of 5 and showed high oral bioavailability (>0.9) and intestinal absorption.
  • Note: Harmane showed a high predicted risk for mutagenicity and hepatotoxicity, requiring further investigation.
• Molecular Docking (Trypanothione Reductase):
  • Harmane exhibited the highest binding affinity (-8.2 kcal/mol), surpassing reference drugs Amphotericin B (-6.1 kcal/mol) and Miltefosine (-8.1 kcal/mol).
  • Abietic acid (-6.9 kcal/mol) and Epiafzelechin trimethyl ether (-7.8 kcal/mol) also showed strong binding.
  • Key interactions involved residues such as CYS52, CYS57, SER162, and THR51, suggesting competitive inhibition of the enzyme's catalytic cycle.

5. Significance and Conclusion

This study establishes Pinus sp. leaf extracts as a promising source of novel antileishmanial leads. The research highlights a multi-faceted mechanism of action:

1. Direct Parasite Killing: Via inhibition of Trypanothione Reductase, disrupting the parasite's redox balance.
2. Host Immune Modulation: Enhancing NO production to kill intracellular amastigotes.
3. Anti-inflammatory/Antioxidant Support: Mitigating the oxidative stress associated with the disease.

The extracts are non-toxic at therapeutic doses (LD50 > 5000 mg/kg) and contain bioactive compounds with favorable pharmacokinetic profiles. While the study identifies Harmane as a potent binder, its predicted toxicity warrants caution. The authors conclude that while the Pinus extract is a strong candidate for drug discovery, future work must focus on the isolation and characterization of individual active compounds, detailed mechanism of action studies, and in vivo efficacy trials to translate these findings into clinical applications.